The Work-Up: Costly Drugs Known as Biologics Prompt Exclusivity Debate
Tuesday, July 21, 2009 - 23:35
in Psychology & Sociology
Companies that own the rights to high-end treatments say allowing copycats to market too soon would hurt financial incentives.